A significant enhancement of therapeutic effect against hepatic metastases of M5076 in mice by a liposomal interleukin-2 (mixture)
- 1 August 2002
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 82 (2-3) , 183-187
- https://doi.org/10.1016/s0168-3659(02)00083-4
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- A novel and simple type of liposome carrier for recombinant interleukin-2Journal of Pharmacy and Pharmacology, 2001
- Pharmacokinetics of interleukin-2 in two anephric patients with metastatic renal cell cancerAnnals of Oncology, 1999
- Stabilization of aerosolized IFN-γ by liposomesInternational Journal of Pharmaceutics, 1999
- Hepatic immunopotentiation by galactose-entrapped liposomal IL-2 compound in the treatment of liver metastasesSurgery Today, 1998
- Active immunotherapy with transiently transfected cytokine-secreting tumor cells inhibits breast cancer metastases in tumor-bearing animalsSurgery, 1996
- Reevaluation of the Superiority of Polyethylene GlycolModified Interleukin-2 Over Regular Recombinant Interleukin-2Journal of Interferon & Cytokine Research, 1995
- Cytokines in liposomes: Preliminary studies with IL-1, IL-2, IL-6, GM-CSF and interferon-γCytokine, 1994
- Antitumor Effect of Interleukin-2 Entrapped in Liposomes on Murine Renal Cell Carcinoma.The Keio Journal of Medicine, 1994
- Immunochemotherapy in B-16-Melanoma-Cell-Transplanted Mice with Combinations of lnterleukin-2, Cyclophosphamide, and PSKOncology, 1994
- The involvement of parenchymal, Kupffer and endothelial liver cells in the hepatic uptake of intravenously injected liposomes effects of lanthanum and gadolinium saltsBiochimica et Biophysica Acta (BBA) - General Subjects, 1981